TCL Archive Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds. December 14, 2001
TCL Archive CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell November 12, 1976
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
